Abstract
Infections after lung transplantation are a major cause of morbidity and mortality. Bacteria, fungus and virus are the most common pathogens at the respiratory tract. This short review analyzes pneumonias in LTR with special emphasis on preventive strategies.
Keywords: Lung transplant, infection, pneumonia, prophylaxis
Current Respiratory Medicine Reviews
Title: Pneumonia in Lung Transplant Recipients
Volume: 6 Issue: 3
Author(s): Isabel Otero, Maria P. Sanjuan, Maria del M. Fernandez-Marrube and Hector Verea
Affiliation:
Keywords: Lung transplant, infection, pneumonia, prophylaxis
Abstract: Infections after lung transplantation are a major cause of morbidity and mortality. Bacteria, fungus and virus are the most common pathogens at the respiratory tract. This short review analyzes pneumonias in LTR with special emphasis on preventive strategies.
Export Options
About this article
Cite this article as:
Otero Isabel, P. Sanjuan Maria, del M. Fernandez-Marrube Maria and Verea Hector, Pneumonia in Lung Transplant Recipients, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526166
DOI https://dx.doi.org/10.2174/157339810791526166 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy West Nile Viral Meningoencephalitis in an Immunocompetent Female: A Case Report from Western Rajasthan, India
Infectious Disorders - Drug Targets Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer's Disease
Current Alzheimer Research Rationale for Peptide and DNA Based Epitope Vaccines for Alzheimers Disease Immunotherapy
CNS & Neurological Disorders - Drug Targets Update on the Pharmacological Treatment of Alzheimers Disease
Current Neuropharmacology Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]
CNS & Neurological Disorders - Drug Targets A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Immunotherapy for Alzheimers Disease: Rational Basis in Ongoing Clinical Trials
Current Pharmaceutical Design COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Antiproliferative and Antifungal Activities of 1,3-diarylpropane-1,3-diones Commonly used as Sunscreen Agents
Letters in Drug Design & Discovery Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Tau as a Therapeutic Target for Alzheimers Disease
Current Alzheimer Research Biotechnological Approaches for Control of Listeria monocytogenes in Foods
Current Biotechnology Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research Nanoneuromedicines for Neurodegenerative Diseases
Nanoscience & Nanotechnology-Asia The Amyloid β-Protein Precursor and Alzheimers Disease. Therapeutic Approaches
Current Medicinal Chemistry - Central Nervous System Agents Kawasakis Disease, Acrodynia, and Mercury
Current Medicinal Chemistry Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Disease Modifying Approaches for Alzheimers Pathology
Current Pharmaceutical Design